Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.Investors Business Daily • 10/04/23
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease TreatmentBusiness Wire • 10/04/23
Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentGlobeNewsWire • 10/04/23
Press Release - Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentGlobeNewsWire • 10/04/23
Sanofi and Janssen join forces to develop E.coli vaccine, with Sanofi's $175M upfront paymentFox Business • 10/03/23
The US Stock Market Could Crack in October: 6 ‘Strong Buy' European Dividend Aristocrats to Buy Now24/7 Wall Street • 09/29/23
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority ReviewGlobeNewsWire • 09/26/23
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia AGlobeNewsWire • 09/25/23
Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate changeGlobeNewsWire • 09/19/23
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From SanofiBusiness Wire • 09/18/23
Sanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the fluPRNewsWire • 09/13/23